SCHEMBL2648366

SCHEMBL2648366

CC1CCC(N(C(=O)Nc2ncc(S(=O)(=O)N3CCCCC3)s2)C2CCCCC2)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.39
POLB P06746 1/20 0.39
RECQL P46063 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.37
NPC1 O15118 1/20 0.37
USP2 O75604 1/20 0.37
HPGD P15428 1/20 0.37
HSD17B10 Q99714 1/20 0.37
KMT2A Q03164 5/20 0.36
MEN1 O00255 4/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
HTT P42858 1/20 0.36
LMNA P02545 1/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 4/20 0.35
PKM P14618 1/20 0.35
MAPK1 P28482 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
CNR2 P34972 1/20 0.35
TP53 P04637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2648362 1.00 ALDH1A1 (0.39) ALDH1A1POLBRECQLSMN1; SMN2NPC1
SCHEMBL2665063 0.88 POLB (0.37) ALDH1A1POLBSMN1; SMN2NPC1KMT2A
SCHEMBL2649468 0.88 POLB (0.37) ALDH1A1POLBSMN1; SMN2NPC1KMT2A
SCHEMBL2649466 0.88 POLB (0.37) ALDH1A1POLBSMN1; SMN2NPC1KMT2A
SCHEMBL999107 0.88 ALDH1A1 (0.38) ALDH1A1POLBRECQLSMN1; SMN2KMT2A
SCHEMBL2647782 0.86 SMN1; SMN2 (0.38) ALDH1A1SMN1; SMN2NPC1KMT2AMEN1
SCHEMBL2647778 0.86 SMN1; SMN2 (0.38) ALDH1A1SMN1; SMN2NPC1KMT2AMEN1
SCHEMBL2648532 0.86 POLB (0.44) ALDH1A1POLBSMN1; SMN2L3MBTL1HTT
SCHEMBL2648989 0.86 POLB (0.44) ALDH1A1POLBSMN1; SMN2L3MBTL1HTT
SCHEMBL2648538 0.86 POLB (0.44) ALDH1A1POLBSMN1; SMN2L3MBTL1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7582769-B2 Dicycloalkyl urea glucokinase activators NOVO NORDISK A/S (DK) 2009-09-01 US disclosed
US-20090118501-A1 Dicycloalkyl Urea Glucokinase Activators NOVO NORDISK A/S (DK) 2009-05-07 US disclosed
EP-1904466-A1 DICYCLOALKYL UREA GLUCOKINASE ACTIVATORS Novo Nordisk A/S (DK) 2008-04-02 EP disclosed
WO-2007006760-A1 DICYCLOALKYL UREA GLUCOKINASE ACTIVATORS NOVO NORDISK A/S (DK) 2007-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090118501-A1 Dicycloalkyl Urea Glucokinase Activators GCK, GCKR, UCK2 ALDH1A1 3782/4885POLB 3011/4885RECQL 3531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.